December 13, 2011 – Demonstrating its continued commitment to patient care, GE Healthcare announced an additional $300 million investment in low-dose technologies and unveiled an array of radiation-dose management offerings today at RSNA 2011. Representing more than $800 million of investment over 15 years, GE Healthcare’s innovative technologies redefine “low dose” with novel dose-reporting solutions, unique image reconstruction techniques, far-reaching Dose Check upgrades, free iPad apps and online courses, and a new informational website, which together help physicians provide patients with unparalleled dose-conscious care.

December 13, 2011 – During RSNA 2011, Bracco explained it is working with the U.S. Food and Drug Administration (FDA) to re-introduce CardioGen-82 (Rubidium Rb 82 Generator) since its recall this past summer.

 

December 13, 2011 – Molecular breast imaging (MBI) has been found to be equivalent to magnetic resonance imaging (MRI) as an adjunct imaging modality in the diagnosis of breast cancer. MBI may be especially useful for the evaluation of high-risk women or those with dense breasts.

 

December 13, 2011 – According to a new study, molecular breast imaging (MBI), can provide critical information in the initial diagnostic workup and surgical planning for patients with newly diagnosed breast cancer. Adding MBI to conventional imaging, namely mammography and ultrasound, enhances pre-surgical planning.

Steris and Toshiba America Medical Systems formed an alliance to offer advanced vascular, cardiovascular, pediatric and neurosurgical hybrid surgical suites to healthcare systems seeking the latest patient-focused interventions.

December 12, 2011 — McKesson announced successful deployment of its Horizon Medical Imaging solution at the first four of 35 hospitals in Ireland as part of an exclusive partnership with the Irish Health Service Executive (HSE). Those hospitals include Beaumont Hospital, Mater Misericordiae University Hospital, Sligo General Hospital and Waterford Regional Hospital.

December 12, 2011 — Revenue Cycle Inc. has again been named the official billing/coding consultant to the American College of Radiation Oncology (ACRO). Ron DiGiaimo, CEO of Revenue Cycle, made the announcement.

December 12, 2011 — An independent panel convened this week by the National Institutes of Health (NIH) has concluded that many men with localized, low-risk prostate cancer could have treatment delayed until warranted by disease progression. These patients would be closely monitored to determine when that point has been reached.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now